Singapore Med J 2008; 49(3) : 181 Editorial Gadolinium chelate-associated nephrogenic systemic fibrosis Kei P L, Chan L P Department of Diagnostic Radiology, Singapore General Hospital, Outram Road, Singapore 169608 Kei PL, MBChB, MMed, FRCR Registrar Chan LP, MBBS, FRCR Consultant ...
Editorial Nephrogenic Systemic Fibrosis, Kidney Disease, and Gadolinium: Is Therea Link? Mark A. Perazella Department of Medicine, Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut Clin JAmSocNephrol ●●: ●●●-●●●, ●●●●. doi: 10.2215/CJN ...
MUMJ Clinical Review 21 CLINICAL RE VIEW INTRODUCTION N ephrogenic systemic fibrosis (NSF) is an emerging disorder that results in widespread tissue fibrosis, occurring exclusively in pa tients with renal imp air-ment.
The Royal College of Radiologists Board of the Faculty of Clinical Radiology Gadolinium-based Contrast Media and Nephrogenic Systemic Fibrosis This document is only available electronically from www.rcr.ac.uk
Nephrogenic Systemic Fibrosis History, Diagnosis & The Registry Shawn E. Cowper, MD Associate Professor of Dermatology and Pathology Yale University New Haven, CT
Consequences of Hypercalcemia: Renal, Fluid and Electrolyte Volume Depletion Decreased intake due to anorexia, nausea and vomiting Nephrogenic diabetes insipidus (NDI) causing free water loss Hypernatremia from Nephrogenic Diabetes Insipidus Renal Insufficiency Decreased blood flow to kidney ...
PHYSIOLOGY IN MEDICINE: A SERIES OF ARTICLES LINKING MEDICINE WITH SCIENCE Physiology in Medicine : Dennis A. Ausiello, MD, Editor ; Dale J. Benos, PhD, Deputy Editor ; Francois Abboud, MD, Associate Editor ; William J. Koopman, MD, Associate Editor Annals of Internal Medicine : Paul Epstein, MD ...
The Journal of Lancaster General Hospital • Winter 2007/2008 • Vol. 2 – No. 4 122 Nephrogenic Systemic Fibrosis – A Clinical and
1565 OVERVIEW Martin R. Prince, MD, PhD • Hong Lei Zhang, MD • Joan C. Prowda, MD • Marc E. Grossman, MD • David N. Silvers, MD The objective of this article is to review the current knowledge about nephrogenic systemic fibrosis (NSF) and how to prevent it.
The appearance of nephrogenic systemic fibrosis (i.e., nephrogenic fibrosing dermopathy) has been reported to be associated with the use of gadolinium-based contrast agents.